Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Sort ascending Bone Marrow Disease
Traipsing Through Muddy Waters: A Critical Review of the Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) Overlap Syndromes Hematology/oncology clinics of North America Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN)
Targeting TP53 Mutations in Myelodysplastic Syndromes Hematology/oncology clinics of North America Myelodysplastic Syndromes (MDS)
Patient stratification in myelodysplastic syndromes: how a puzzle may become a map Hematology. American Society of Hematology. Education Program Myelodysplastic Syndromes (MDS)
Therapy for lower-risk MDS Hematology. American Society of Hematology. Education Program Myelodysplastic Syndromes (MDS)
Existing agents, novel agents, or transplantation for high-risk MDS Hematology. American Society of Hematology. Education Program Myelodysplastic Syndromes (MDS)
Lowering the boom on lower-risk myelodysplastic syndromes Hematology. American Society of Hematology. Education Program Myelodysplastic Syndromes (MDS)
Monitoring and treatment of MDS in genetically susceptible persons Hematology. American Society of Hematology. Education Program Myelodysplastic Syndromes (MDS)
Genetic predisposition to MDS: diagnosis and management Hematology. American Society of Hematology. Education Program Myelodysplastic Syndromes (MDS)
Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome Hematology. American Society of Hematology. Education Program Aplastic Anemia
Outpatient transfusions for myelodysplastic syndromes Hematology. American Society of Hematology. Education Program Myelodysplastic Syndromes (MDS)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.